Current Challenges and Future Trends of Enzymatic Paper-Based Point-of-Care Testing for Diabetes Mellitus Type 2

Abstract

A point-of-care (POC) can be defined as an in vitro diagnostic test that can provide results within minutes. It has gained enormous attention as a promising tool for biomarkers detection and diagnosis, as well as for screening of chronic noncommunicable diseases such as diabetes mellitus. Diabetes mellitus type 2 is one of the metabolic disorders that has grown exponentially in recent years, becoming one of the greatest challenges to health systems. Early detection and accurate diagnosis of this disorder are essential to provide adequate treatments. However, efforts to reduce incidence should remain not only in these stages but in developing continuous monitoring strategies. Diabetes-monitoring tools must be accessible and affordable; thus, POC platforms are attractive, especially paper-based ones. Paper-based POCs are simple and portable, can use different matrixes, do not require highly trained staff, and are less expensive than other platforms. These advantages enhance the viability of its application in low-income countries and hard-to-reach zones. This review aims to present a critical summary of the main components required to create a sensitive and affordable enzymatic paper-based POC, as well as an oriented analysis to highlight the main limitations and challenges of current POC devices for diabetes type 2 monitoring and future research opportunities in the field.

The importance, benefits, and future of nanobiosensors for infectious diseases

“…Furthermore, rather than a lack of fundamental understanding, the existing restrictions on the availability of biosensors are more a result of an absence of suitable production technology and cost-effectiveness. 90 Biosensors offer improved identification, accuracy, and precision for detecting infectious diseases. 91 They provide excellent selectivity and sensitivity due to specialized biorecognition components.…”

A Review on Non-Enzymatic Electrochemical Biosensors of Glucose Using Carbon Nanofiber Nanocomposites

“…Hyperglycemia is the second phenomenon that undesirably influences the kidneys, eyes, nerves, and blood vessels, causing blood sugar levels to rise abnormally [ 8 , 9 , 10 ]. As a result of insufficient insulin production in the body (Type-1 diabetes) or not being able to use the insulin produced in the body (Type-2 diabetes), diabetes is defined by hyperglycemia, or a high blood glucose level [ 11 , 12 , 13 ]. The hormone insulin aids the cells of the body in absorbing glucose in the blood.…”

TMBvsABTS: comparison of multi‐enzyme‐based approaches for the colorimetric quantification of salivary glucose

“…Furthermore, saliva contains >800 metabolites including proteins, enzymes, antibodies, sugars and other molecules 7 . For this reason, saliva has drawn the attention of researchers owing to its enormous potential for diagnostic purposes 8,9 …”

“…7 For this reason, saliva has drawn the attention of researchers owing to its enormous potential for diagnostic purposes. 8,9 Recently, a growing body of evidence on saliva applicability in disease diagnosis and control has accumulated. [10][11][12] However, the diffusion of its use as a source of biomarkers depends on the development of inexpensive and simple techniques in terms of training and equipment.…”